Results 61 to 70 of about 1,516,429 (359)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections

open access: yesJournal of Ophthalmology, 2018
Intravitreal injection of a therapeutic substance is the most common procedure performed in ophthalmology. It has a low incidence of serious complications but is associated with a small chance of endophthalmitis.
P. Lau   +2 more
semanticscholar   +1 more source

Treatment chronic macular edema in Vogt-Koyanagi Harada syndrome with dexamethasone intravitreal implant: description of three case [PDF]

open access: yes, 2015
Purpose: To report our experience with dexamethasone intravitreal implant (Ozurdex, DEX implant) in the chronic cystic macular edema (ME )with Vogt-Koyanagi-Harada (VKH) Syndrome. Method: A retrospective chart review of three patients with (VKH) treated
Albanese, Giorgio   +5 more
core   +1 more source

Intravitreal Injection—Technique and Safety

open access: yesAsia-Pacific Journal of Ophthalmology, 2015
Intravitreal (IVT) injection of therapeutic agents has become one of the most commonly performed procedures in ophthalmology. Over the past decade, a number of guidelines have been published that recommend proper techniques to increase the safety of IVT injections.
Dennis S.C. Lam   +3 more
openaire   +2 more sources

Hydrodynamics of Intravitreal Injections into Liquid Vitreous Substitutes

open access: yesPharmaceutics, 2019
Intravitreal injections have become the cornerstone of retinal care and one of the most commonly performed procedures across all medical specialties.
C. Henein   +6 more
semanticscholar   +1 more source

Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules [PDF]

open access: yes, 2019
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal therapeutic agents for the treatment of dry age-related macular degeneration (AMD), such as neuroprotective drugs, and complement inhibitors, also called ...
Cerini, Alberto   +5 more
core   +1 more source

Subconjunctival anaesthesia for intravitreal injections [PDF]

open access: yesEye, 2013
Sir, We read with interest the paper by Lyall et al,1 who report the results of an observational study of infective endophthalmitis in the United Kingdom following intravitreal anti-VEGF injection. Using 200 patients selected from 10 control centres, the authors identified 3 endophthalmitis patients, compared to 1 control patient, who had ...
Alexander, P., Sahu, D., Lotery, A.J.
openaire   +4 more sources

Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects

open access: yesInternational Journal of Retina and Vitreous, 2019
A paracentesis prior to an intravitreal injection is a very safe procedure and can prevent IOP-spikes after injections. As these spikes pose the risk of inducing glaucomatous changes particularly in patients with frequent injections and/or with a risk ...
S. Saxena   +41 more
semanticscholar   +1 more source

Evolutionary Multi-Task Injection Testing on Web Application Firewalls [PDF]

open access: yesarXiv, 2022
Web application firewall (WAF) plays an integral role nowadays to protect web applications from various malicious injection attacks such as SQL injection, XML injection, and PHP injection, to name a few. However, given the evolving sophistication of injection attacks and the increasing complexity of tuning a WAF, it is challenging to ensure that the ...
arxiv  

Intravitreal injection: balancing the risks [PDF]

open access: yesEye, 2007
Intravitreal triamcinolone (iVTA) had gathered pace in the management of retinal diseases. By simply searching with the string ‘intravitreal triamcinolone’ in PubMed, it returns over 400 publications, with over 300 in the past 2 years. Despite the large number of publications, there are still very limited data on long-term efficacy (over 12 months ...
T. Adewoyin, N V Chong
openaire   +2 more sources

Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol. [PDF]

open access: yes, 2020
AimTo show the characteristics and outcomes of patients with neovascular age-related macular degeneration (nAMD) who had extended remission (ER) while on a pro re nata (PRN) treatment protocol.MethodsThis was a retrospective case-control study of a ...
Amador-Patarroyo, Manuel J   +6 more
core  

Home - About - Disclaimer - Privacy